These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26685491)

  • 21. E-prescription errors and their resolution in a community compounding pharmacy.
    Reed-Kane D; Vasquez K; Pavlik A; Peragine J; Sandberg M
    Int J Pharm Compd; 2014; 18(2):159-61. PubMed ID: 24881120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Practical guidelines to ensure the quality of compounded preparations in community pharmacies].
    Wauters K; Vandeputte A; De Paepe K
    J Pharm Belg; 2017 Mar; (1):14-24. PubMed ID: 30281230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. National survey of quality assurance activities for pharmacy-prepared sterile products in hospitals.
    Crawford SY; Narducci WA; Augustine SC
    Am J Hosp Pharm; 1991 Nov; 48(11):2398-413. PubMed ID: 1746573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential elements of quality control.
    Boylan JC
    Am J Hosp Pharm; 1983 Nov; 40(11):1936-9. PubMed ID: 6650523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compounding pharmacies: before and after an inspection.
    Kulkarni D; Ricketts S
    Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International Academy of Compounding Pharmacists Legislative/Regulatory Update.
    Rice B
    Int J Pharm Compd; 2017; 21(3):212-213. PubMed ID: 28557782
    [No Abstract]   [Full Text] [Related]  

  • 27. Basic of compounding: Repackaging, Part 1.
    Allen LV
    Int J Pharm Compd; 2013; 17(1):54-60. PubMed ID: 23627248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety Standards in Pharmaceutical Compounding, Part 1: The Occupational Safety and Health Administration.
    Greeson NMH; Mixon W; Allan WC
    Int J Pharm Compd; 2020; 24(4):270-276. PubMed ID: 32649298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compounding pharmacies: who is in charge?
    Pergolizzi JV; Labhsetwar S; LeQuang JA
    Pain Pract; 2013 Mar; 13(3):253-7. PubMed ID: 23350709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Improving the quality of compounded medicines through self-assessment: proof of concept].
    Wauters K; Fierens C; Corthout J; Sarre S; Saevels J
    J Pharm Belg; 2014 Jun; (2):26-33. PubMed ID: 25055453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of enhanced compounding vigilance: Three perspectives.
    Lucarotti A; Kent S; Strickland J; Desmond JS
    Am J Health Syst Pharm; 2020 Jun; 77(13):1071-1077. PubMed ID: 32382741
    [No Abstract]   [Full Text] [Related]  

  • 32. "Double, double, toil and trouble': for modern practitioners of compounding, standards and training are critical [interview by Lisa Santandrea].
    Allen LV
    Am J Nurs; 2003 May; 103(5):83. PubMed ID: 12762333
    [No Abstract]   [Full Text] [Related]  

  • 33. Obtaining accreditation by the pharmacy compounding accreditation board, part 1: an overview.
    Cabaleiro J
    Int J Pharm Compd; 2007; 11(4):297-8. PubMed ID: 23974788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacy standards for clinical trials].
    Terkola R
    Onkologie; 2008; 31 Suppl 2():25-8. PubMed ID: 18487865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compounding practices and beliefs of Arizona pharmacists.
    Cauthon KA; Bowman BJ; Gurney MK
    Int J Pharm Compd; 2013; 17(2):154-61. PubMed ID: 23696176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APhA house of delegates endorses policies on pharmaceutical care, therapeutic outcomes, compounding, packaging.
    Am J Hosp Pharm; 1992 Jun; 49(6):1318. PubMed ID: 1529970
    [No Abstract]   [Full Text] [Related]  

  • 37. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacists' opinions about and compliance with recommendations for intravenous admixture practices.
    Brzozowski DF; Hale KM; Segal R; Mirtallo JM
    Am J Hosp Pharm; 1987 Sep; 44(9):2077-84. PubMed ID: 3479020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.